Table 1.
Characteristic | Received IORT n=71 (%) | no IORT n=18(%) |
---|---|---|
Mean age (range) | 64.8 (48–92) | 65.9 (48–83) |
Clinical Staging | ||
cT1a | 2 (2.8%) | 3 (17%) |
cT1b | 18 (25%) | 9 (50%) |
cT1c | 35 (49%) | 4 (22%) |
cT2 (<3cm) | 16 (23%) | 2 (11%) |
cN0 | 89 (100%) | |
Grade | ||
I | 25 (35%) | 5 (28%) |
II | 24 (34%) | 9 (50%) |
III | 22 (31%) | 4 (22%) |
Markers | ||
ER+ | 56 (79%) | 15 (83%) |
PR+ | 49 (69%) | 10 (56%) |
HER2+ | 7 (10%) | 1 (5.6%) |
ER+, PR+, HER2− | 46 (65%) | 10 (56%) |
“triple negative” | 12 (17%) | 2 (11%) |